Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.7600
- TODAY'S CHANGE (%)-0.1800 (-2.2670%)
- Bid / Lots7.8000/ 1
- Ask / Lots8.0900/ 4
- Open / Previous Close7.9100 / 7.9400
- Day Range
- 52 Week Range
- Volume2,048,155
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 192158 | 7.8111 |
| 09:34 ET | 1500 | 7.86 |
| 09:36 ET | 4400 | 7.78 |
| 09:38 ET | 4550 | 7.7816 |
| 09:41 ET | 1196 | 7.815 |
| 09:43 ET | 3268 | 7.87 |
| 09:45 ET | 3598 | 7.89 |
| 09:48 ET | 400 | 7.87 |
| 09:50 ET | 1034 | 7.87 |
| 09:52 ET | 11669 | 7.85 |
| 09:54 ET | 1940 | 7.87 |
| 09:56 ET | 10987 | 7.86 |
| 09:57 ET | 1000 | 7.8602 |
| 09:59 ET | 800 | 7.89 |
| 10:01 ET | 301 | 7.88 |
| 10:03 ET | 1100 | 7.88 |
| 10:06 ET | 3776 | 7.88 |
| 10:08 ET | 400 | 7.85 |
| 10:10 ET | 800 | 7.845 |
| 10:12 ET | 700 | 7.78 |
| 10:14 ET | 400 | 7.7883 |
| 10:15 ET | 3826 | 7.81 |
| 10:17 ET | 511 | 7.82 |
| 10:19 ET | 700 | 7.84 |
| 10:21 ET | 700 | 7.83 |
| 10:26 ET | 6861 | 7.79 |
| 10:28 ET | 500 | 7.81 |
| 10:32 ET | 1300 | 7.82 |
| 10:33 ET | 300 | 7.81 |
| 10:39 ET | 100 | 7.8 |
| 10:42 ET | 100 | 7.8 |
| 10:44 ET | 300 | 7.81 |
| 10:46 ET | 2578 | 7.79 |
| 10:48 ET | 5808 | 7.78 |
| 10:50 ET | 4087 | 7.807 |
| 10:51 ET | 2300 | 7.79 |
| 10:53 ET | 100 | 7.79 |
| 10:55 ET | 600 | 7.81 |
| 11:00 ET | 900 | 7.808 |
| 11:02 ET | 500 | 7.8094 |
| 11:04 ET | 1302 | 7.78 |
| 11:06 ET | 200 | 7.78 |
| 11:08 ET | 1279 | 7.79 |
| 11:09 ET | 300 | 7.785 |
| 11:13 ET | 6200 | 7.79 |
| 11:15 ET | 100 | 7.79 |
| 11:18 ET | 6922 | 7.775 |
| 11:20 ET | 1257 | 7.7821 |
| 11:22 ET | 100 | 7.8 |
| 11:24 ET | 100 | 7.7999 |
| 11:26 ET | 2140 | 7.77 |
| 11:27 ET | 468 | 7.78 |
| 11:29 ET | 100 | 7.79 |
| 11:31 ET | 1533 | 7.77 |
| 11:33 ET | 1451 | 7.76 |
| 11:36 ET | 2823 | 7.77 |
| 11:38 ET | 1239 | 7.78 |
| 11:40 ET | 800 | 7.79 |
| 11:42 ET | 200 | 7.79 |
| 11:44 ET | 100 | 7.79 |
| 11:45 ET | 4245 | 7.82 |
| 11:47 ET | 763 | 7.81 |
| 11:49 ET | 100 | 7.8099 |
| 11:51 ET | 100 | 7.8 |
| 11:54 ET | 400 | 7.78 |
| 11:56 ET | 3600 | 7.795 |
| 11:58 ET | 518 | 7.809 |
| 12:02 ET | 1100 | 7.805 |
| 12:03 ET | 1217 | 7.82 |
| 12:05 ET | 1950 | 7.84 |
| 12:07 ET | 600 | 7.83 |
| 12:12 ET | 200 | 7.83 |
| 12:14 ET | 794 | 7.8199 |
| 12:18 ET | 1400 | 7.81 |
| 12:20 ET | 821 | 7.81 |
| 12:21 ET | 200 | 7.805 |
| 12:23 ET | 300 | 7.805 |
| 12:25 ET | 100 | 7.8 |
| 12:27 ET | 200 | 7.805 |
| 12:30 ET | 875 | 7.79 |
| 12:32 ET | 1035 | 7.79 |
| 12:34 ET | 100 | 7.77 |
| 12:36 ET | 8850 | 7.78 |
| 12:38 ET | 1874 | 7.78 |
| 12:39 ET | 1262 | 7.81 |
| 12:41 ET | 200 | 7.8 |
| 12:43 ET | 500 | 7.8 |
| 12:45 ET | 100 | 7.8 |
| 12:48 ET | 500 | 7.79 |
| 12:50 ET | 400 | 7.79 |
| 12:52 ET | 973 | 7.79 |
| 12:54 ET | 200 | 7.795 |
| 12:59 ET | 266 | 7.79 |
| 01:01 ET | 2951 | 7.79 |
| 01:03 ET | 712 | 7.79 |
| 01:08 ET | 100 | 7.785 |
| 01:10 ET | 869 | 7.784 |
| 01:12 ET | 112 | 7.79 |
| 01:14 ET | 1655 | 7.78 |
| 01:15 ET | 100 | 7.785 |
| 01:17 ET | 612 | 7.78 |
| 01:19 ET | 633 | 7.785 |
| 01:21 ET | 300 | 7.785 |
| 01:24 ET | 5625 | 7.78 |
| 01:26 ET | 500 | 7.78 |
| 01:28 ET | 265 | 7.78 |
| 01:30 ET | 400 | 7.78 |
| 01:32 ET | 600 | 7.78 |
| 01:33 ET | 100 | 7.77 |
| 01:35 ET | 200 | 7.77 |
| 01:37 ET | 400 | 7.77 |
| 01:39 ET | 300 | 7.78 |
| 01:42 ET | 756 | 7.78 |
| 01:44 ET | 600 | 7.78 |
| 01:46 ET | 473 | 7.77 |
| 01:48 ET | 2610 | 7.78 |
| 01:50 ET | 2700 | 7.78 |
| 01:51 ET | 100 | 7.78 |
| 01:53 ET | 1851 | 7.8 |
| 01:55 ET | 200 | 7.8 |
| 01:57 ET | 100 | 7.8 |
| 02:00 ET | 3591 | 7.81 |
| 02:02 ET | 100 | 7.81 |
| 02:04 ET | 100 | 7.8 |
| 02:06 ET | 1215 | 7.8 |
| 02:08 ET | 100 | 7.8 |
| 02:09 ET | 100 | 7.8 |
| 02:11 ET | 415 | 7.79 |
| 02:13 ET | 1000 | 7.8 |
| 02:18 ET | 212 | 7.8 |
| 02:20 ET | 200 | 7.8 |
| 02:22 ET | 1186 | 7.81 |
| 02:24 ET | 928 | 7.825 |
| 02:26 ET | 212 | 7.82 |
| 02:27 ET | 1914 | 7.8212 |
| 02:29 ET | 233 | 7.8299 |
| 02:31 ET | 993 | 7.81 |
| 02:33 ET | 219 | 7.8 |
| 02:36 ET | 209 | 7.79 |
| 02:38 ET | 100 | 7.79 |
| 02:40 ET | 600 | 7.81 |
| 02:42 ET | 100 | 7.81 |
| 02:44 ET | 4050 | 7.83 |
| 02:45 ET | 2017 | 7.845 |
| 02:47 ET | 100 | 7.84 |
| 02:49 ET | 200 | 7.84 |
| 02:51 ET | 1073 | 7.84 |
| 02:54 ET | 300 | 7.845 |
| 02:56 ET | 9923 | 7.83 |
| 02:58 ET | 753 | 7.815 |
| 03:00 ET | 1100 | 7.805 |
| 03:02 ET | 5932 | 7.81 |
| 03:03 ET | 400 | 7.81 |
| 03:05 ET | 1212 | 7.8 |
| 03:07 ET | 1200 | 7.8 |
| 03:09 ET | 11921 | 7.79 |
| 03:12 ET | 7972 | 7.7801 |
| 03:14 ET | 5169 | 7.79 |
| 03:16 ET | 400 | 7.78 |
| 03:18 ET | 1268 | 7.775 |
| 03:20 ET | 915 | 7.775 |
| 03:21 ET | 500 | 7.77 |
| 03:23 ET | 3851 | 7.795 |
| 03:25 ET | 1175 | 7.79 |
| 03:27 ET | 200 | 7.79 |
| 03:30 ET | 1597 | 7.825 |
| 03:32 ET | 3201 | 7.835 |
| 03:34 ET | 400 | 7.835 |
| 03:36 ET | 2125 | 7.83 |
| 03:38 ET | 100 | 7.83 |
| 03:39 ET | 1942 | 7.85 |
| 03:41 ET | 3970 | 7.84 |
| 03:43 ET | 400 | 7.84 |
| 03:45 ET | 400 | 7.84 |
| 03:48 ET | 8688 | 7.8 |
| 03:50 ET | 783 | 7.81 |
| 03:52 ET | 13228 | 7.815 |
| 03:54 ET | 14097 | 7.81 |
| 03:56 ET | 11890 | 7.79 |
| 03:57 ET | 14265 | 7.77 |
| 03:59 ET | 1134261 | 7.76 |
Sep 10, 2024
Vir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 22, 2024
Vir Biotechnology to Participate in the Morgan Stanley 22(nd) Annual Global Healthcare Conference, from 8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.2B | -21.4x | --- |
Zymeworks Inc | 927.2M | -8.6x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.7x | --- |
Silence Therapeutics PLC | 854.3M | -15.4x | --- |
Silence Therapeutics PLC | 859.0M | -14.2x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
